• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad , Nov. 29

French vaccine major Merieux Alliance will locate its global prophylactic vaccine research and development centre in Hyderabad.

The State Government would provide the infrastructural facilities and land at Karakapatla, Phase III of the Biotech Park.

Dr Alan Merieux, Chairman of the Lyon-based Merieux Group, Dr Georges Hibon, Chairman, Shantha Biotechnics Ltd, Hyderabad, Mr K.I. Varaprasada Reddy, Founder & Managing Director of Shantha Biotechnics and Mr Khalil Ahmed, Executive Director, met the Andhra Pradesh Chief Minister, Dr Y.S. Rajasekhara Reddy, and discussed the issue today.

The team discussed the manufacturing and marketing of a recombinant human healthcare product, according to a release from the Chief Minister's Office here.

The French Group had early this month acquired a major stake in Shantha Biotechnics, which specialised in indigenous development of recombinant vaccines.

They picked up the stake from Oman Bank and other investors from Oman.

Mr Varaprasada Reddy, the founder and Khalil Ahmed, together owning about 20 per cent did not divest and were retained or given bigger roles.

More Stories on : New Projects | Research & Development | Alliances & Joint Ventures | Andhra Pradesh

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Shantha to be global vaccine hub for Alliance Merieux

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line